Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
Second Edition BOGP (0)
Canada (1)
Organization / System Development
Musculoskeletal/Multiple Sclerosis (MS) (1)
Patient Advocacy Organization (4)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Capacity and capabilities for engagement
Clinical study phase III